SCHLAGWORTE: Life Sciences
4TEEN4 erweitert Series-C-Finanzierungsrunde auf 55 Mio. EUR
Die 4TEEN4 Pharmaceuticals GmbH („4TEEN4“) gibt die Erweiterung ihrer Series-C-Finanzierung auf 55 Mio. EUR bekannt, an der sich bestehende und neue Investoren beteiligen. Das...
‘Out of the lab, straight to the market’
The life sciences sector is regarded as one of the most promising growth markets of the future. Germany is a hightech nation, and its...
Enabling Discovery: How WuXi AppTec’s Crelux Accelerates Biotech Innovation
At Crelux, a WuXi AppTec company in Munich, innovation starts with access. Through strategic collaborations and state-of-the-art technology, Crelux enables start-ups and biotechs to...
‘We aim to set new standards in respiratory medicine with ATL-105’
AATec develops new therapeutics for inflammatory lung diseases based on a new recombinant version of alpha-1 antitrypsin. Backed by a pre-series A funding round...
Now online: Impact Life Sciences 04/2025!
In the newest Impact Life Sciences Special, we explore current technology trends – this time with a focus on medical technology. Industry experts provide...
“We’re supercharging T cells to fight solid tumors”
After a strategic refocus last year, Berlin- and San Francisco-based T-knife is entering a new phase in its mission to bring the promise of...
Buchtipp: The Honorable Entrepreneur, Dr. Philipp Baaske
Zwei junge Wissenschaftler starten im Keller der LMU München und bauen ein global erfolgreiches Biotech-Unternehmen auf: NanoTemper Technologies GmbH. Ohne Venture Capital, ohne Exit-Mantra....
A golden era for drugs and devices
The global obesity crisis has evolved into one of the most significant healthcare
challenges of the 21st century. With over one billion people worldwide now...
‘What drives me is the vision to transform cancer care worldwide’
Theranostics, with its special subfield called radiotheranostics, is an innovative
approach that combines diagnostic imaging and targeted therapy using radionuclides to detect and treat cancer,...
Now online: The Impact Life Sciences Network
Our WHO IS WHO offers insight into the scene and its players, as well as initial guidance in your search for the right contacts...
Crowdfunding in the life sciences
Crowdfunding is a method of raising money to finance projects by collecting small contributions from a large number of people, typically via online platforms....
Patient communication is more than just bedside manners
Good healthcare has always relied on precise communication. But what happens when patients don’t understand the language spoken by the medical staff? In a...
Next-generation therapies
Ningaloo Biosystems’ technology enables the control of biological processes in living cells using light, thereby improving the productivity, quality, scalability, and reliability of pharmaceutical...
Amass sichert sich 1,4 Mio. EUR Seed-Finanzierung
Die KI-Plattform Amass hat eine Seed-Runde in Höhe von 1,4 Mio. EUR abgeschlossen. Angeführt wurde die Finanzierung von Giant Ventures, beteiligt sind zudem der...
Berlin bleibt Investitionsmagnet: Life Sciences und Fintech im Fokus
Berlin behauptet sich auch 2025 als Hotspot für Investitionen und Innovationen. Im ersten Halbjahr wurden laut der aktuellen Bilanz der Wirtschaftsfördergesellschaft Berlin Partner 668...